All Press Releases for June 22, 2022

Kaimi Biotech Presents Innovative Color Changing Swab-QiDix at 2022 AACC

First of its kind, QiDix makes sampling easier

The QiDix swab is compatible with both PCR based molecular assays and immunoassays.

    TAIZHOU, CHINA, June 22, 2022 /24-7PressRelease/ -- Taizhou Kaimi Biotech Co., Ltd. (Kaimi Biotech) will be exhibiting at the upcoming 2022 AACC Annual Scientific Meeting & Clinical Lab Expo in Chicago, Illinois,from July 24 to 28 and will introduce innovative QiDix color changing swab, first of its kind in the world. Please visit Kaimi Biotech at booth #4843. The QiDix swab has been registered with FDA of United States of America and can be used in USA markets. The QiDix Swab has also been registered with CFDA of China and used in China markets.

The QiDix swab is the first color changing swab in the market and can be used to collect various types of body fluids, including saliva, nasal mucus and urine, etc. The color indicator on swabs can help users to determine if enough samples have been collected and if the sample has been released into dilution buffer before testing. The QiDix swab is compatible with both PCR based molecular assays and immunoassays.

"We are looking forward to sharing our new swabs with point of care test device manufacturers at the AACC Annual Meeting," said Otis Zhao, President and Co-founder of Kaimi Biotech. "Our breakthrough innovation can enhance user experience, and assure correct sample collection."

Kaimi Biotech, located in Jiangsu, China, develops and manufactures novel medical diagnostic products with our proprietary technologies. We firmly believe that excellent products rely on innovation and robust production processes. we are fully committed to investing on development of novel materials and manufacturing processes to deliver new products with great performance and help our customers solve challenges of medical diagnostics.

Related Link:

# # #

Contact Information

Kai Mi
Taizhou Kaimi Biotech Co., Ltd.
Taizhou, Jiangsu
Voice: +86-523-8620-9880
E-Mail: Email Us Here
Website: Visit Our Website
Follow Us: